bpc 157 safety humans in Australia: Benefits, side effects, risks and legality Should YOU Be Taking BPC-157
Description
BioMed Research International 2021:9924314
Deficiency leads to methylmalonic acid accumulation, which can cause neurological damage over time
Pharmacological limitations of phage therapy
Start with minimal weight (1 to 2 pounds) and progress based on tolerance
No tolerance development to the lipolytic effects was noted in these studies, suggesting that unlike beta-2 agonists (which rapidly desensitize their receptors), beta-3 receptor activation may not produce the same downregulation pattern
